Björn Stollenwerk, PhD
Amgen (Europe) GmbH
Dammstrasse 23
Zug
Switzerland
6301
Papers:
MODELLING ETELCALCETIDE EFFECTIVENESS ON HEALTH OUTCOMES: RELATING BIOCHEMICAL OUTCOMES TO MORTALITY, CARDIOVASCULAR EVENTS, FRACTURES AND PARATHYROIDECTOMY